Clinuvel Pharmaceuticals Limited

ASX:CUV.AX

14.8 (AUD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Operating Activities:
Net Income 35.63630.60520.87824.72815.05118.13413.2247.181-3.121-10.398-5.526-6.803-9.767-11.409-11.521-15.373-14.656-9.176-10.769-11.0290-3.977-3.141-1.558
Depreciation & Amortization 1.1420.7890.7580.8610.4460.2140.0450.0530.0260.0270.0370.0580.0620.0920.7160.8310.8420.9050.9150.8240.790.7940.0380.783
Deferred Income Tax 0-19.7546.0650.88-3.51-0.019-0.282-1.8211.438-4.482-0.3540.499000000000000
Stock Based Compensation 08.996.1212.6021.6590.140.4280.3951.675.6760.1950.487000000000000
Change In Working Capital -6.444-3.2175.891-11.4171.818-0.561-1.2511.425-3.108-1.1940.159-0.986000000000000
Accounts Receivables -4.024-6.013-0.113-9.476-2.4560.934-1.8511.585-2.863-0.3570.159-0.986000000000000
Inventory -1.107-7.6881.355-1.8990.848-1.4950.6-0.159-0.245-0.83700000000000000
Accounts Payables -0.6484.515-1.563-0.022.6611.5120.2060.73-0.297000000000000000
Other Working Capital -0.6655.9686.213-0.0220.765-1.512-0.206-0.730.2970.5810.6270.516000000000000
Other Non Cash Items 14.78319.50.1591.607-1.2760.548-0.470.862-0.5031.360.3260.352-0.3181.83-0.9783.5576.6330.092-1.5490.959-6.7933.1830.6130.26
Operating Cash Flow 37.05436.91239.87219.26214.18818.45611.6939.917-5.037-4.53-4.809-6.892-10.023-9.487-11.783-10.986-7.181-8.179-11.403-9.246-6.0030-2.49-0.515
Investing Activities:
Investments In Property Plant And Equipment -5.576-1.028-0.434-0.854-0.889-0.258-0.075-0.067-0.098-0.012-0.003-0.031-0.005-0.07-0.045-0.032-0.221-0.44-0.363-1.1-0.043-0.075-0.076-0.078
Acquisitions Net 00000000000000006.440000000
Purchases Of Investments -23.458000000000000000-21.965-26.484-1.99400000
Sales Maturities Of Investments 000000000000.4674.7992.6159.6886.55521.4450000000
Other Investing Activites 0000000000.00100.4670000-6.440.45000000
Investing Cash Flow -29.034-1.028-0.434-0.854-0.889-0.258-0.075-0.067-0.098-0.011-0.0030.4374.7942.5469.6436.522-0.742-26.475-2.357-1.1-0.043-0.075-0.076-0.078
Financing Activities:
Debt Repayment 0-0.264-0.268-0.2-0.243-0.07000000000000000000
Common Stock Issued 4.1550000000.0858.2990.256.9216.6235.76000.1440.0861.79318.26110.169.7941.19801.606
Common Stock Repurchased -4.9090000000-0.036-0.027-0.039-0.34800-0.0020-0.079-1.769-0.657-0.531-0.88-0.0020-0.602
Dividends Paid -2.47-1.976-1.235-1.235-1.224-0.957000000000000000000
Other Financing Activities -0.347-0.264-0.268-0.044-0.019-0.00400.0850.125-0.027-0.039-0.3480000-0.079-1.769-0.657-0.531-0.880.1180-0.602
Financing Cash Flow -3.572-2.24-1.504-1.48-1.486-1.03100.0858.3880.2236.8826.2755.760-0.0020.1440.00160.02417.6039.6298.9141.31401.004
Other Information:
Effect Of Forex Changes On Cash -1.141.660.884-0.9830.6640.9020.828-0.0270.0190.265-0.0130.030.009-0.296-0.1540.278-0.168-0.134000000
Net Change In Cash 3.308-3.542-9.73211.489-0.09218.0712.4469.9083.272-4.0532.057-0.150.541-7.237-2.296-4.042-8.0925.2363.843-0.7182.869-1.802-2.5660.412
Cash At End Of Period 35.20123.86727.40937.14125.65254.26936.19823.75213.84510.57214.62612.56912.71912.17819.41521.71125.75233.8428.6064.7635.482.6124.4146.981